Previous close | 8.35 |
Open | 8.56 |
Bid | 8.10 x 800 |
Ask | 8.88 x 1000 |
Day's range | 7.95 - 8.72 |
52-week range | 6.54 - 49.51 |
Volume | |
Avg. volume | 305,053 |
Market cap | 355.395M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.94 |
Earnings date | 10 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 70.90 |
The big shareholder groups in COMPASS Pathways plc ( NASDAQ:CMPS ) have power over the company. Insiders often own a...
LONDON, May 12, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in two upcoming events as follows: Citi’s Biopharma Virtual Co-Panel Day: panel “Mood Disorders/Mental Health Panel” at 11:00 am ET on 18 May 2022HC Wainwright Global Investments Conference: presentation at 9:00 am ET on 24 May 2022 A live audio webcast of
Good morning, and welcome to COMPASS Pathways first quarter '22 earnings call. Again, my name is Stephen Schultz, senior vice president of investor relations at COMPASS Pathways. Today, I'm joined by George Goldsmith, chairman and chief executive officer; Dr.